Clinical trial
Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1…
NCT00391625 · Shire, Industry · Completed
Key facts
| NCT number | NCT00391625 |
|---|---|
| Title | Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A (ERT) |
| Official title | An Open-Label Extension of Study TKT025 Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A Enzyme Replacement Therapy |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Gaucher Disease |
| Intervention type | Drug |
| Interventions | GA-GCB |
| Enrollment | 10 |
| Start date | Sep 13, 2004 |
| Primary completion | Jan 31, 2008 |
| Completion | Jan 31, 2008 |
| First posted | Oct 24, 2006 |
| Last update posted | Jun 22, 2021 |
| Countries | Israel, Romania, Serbia |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: